🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetics of 50 mg BIBR 1048 administered as two newly developed...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT02170805
To assess the extent of absorption of 12.5, 50 and 200 mg of BIBR 1048 MS w...
Status
Completed
Location
Multiple Locations
Start Date
2001-02
Trial ID
NCT02170792
Treatments Being Tested
Two substudies to assess (1) the tolerability of BIBR 953 ZW intravenous in...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT02170584
Treatments Being Tested
To investigate safety, pharmacokinetics and pharmacodynamics of BIBR 1048 M...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT02171000
Treatments Being Tested
The objective of this study was to assess safety, pharmacokinetics and the ...
Status
Completed
Location
Multiple Locations
Start Date
1998-11
Trial ID
NCT02170116
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-05
Trial ID
NCT02170831
Study to investigate whether and to what extent the suggested P-glycoprotei...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT02173717
Treatments Being Tested
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-11
Trial ID
NCT02170740
Treatments Being Tested
To assess the extend of absorption of 12.5, 25, 50 and 100 mg of BIBR 1048 ...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02170766
Treatments Being Tested